Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesOther spirochetal diseasesICD-10-CM a69-other-spirochetal-infections
    Ask Trek AI about this page

    ICD-10-CM Code For Other Spirochetal Infections: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group A69 includes infections caused by spirochetes other than those classified under Lyme disease, such as erythema chronicum migrans equivalents and other specified spirochetal diseases, covering localized and systemic presentations. These ICD-10-CM diagnosis codes are used to document clinical encounters for spirochetal infections, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM A69 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Other Spirochetal Infections: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM A69: Other Spirochetal Infections Overview

    The diagnoses in this group represent infections caused by non-lyme spirochetal organisms affecting multiple body systems, commonly presenting with dermatologic, neurologic, or systemic signs. These conditions target infectious disease processes and may involve skin, nervous system, or other organs depending on the pathogen and stage. Accurate coding matters for appropriate clinical documentation and reimbursement because it communicates disease specificity and severity to payers and supports correct claim adjudication.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a patient has a documented diagnosis of a non-lyme spirochetal infection or a specified clinical syndrome attributed to a spirochete. Assign the code that best reflects the specific organism, site of involvement, and documented clinical manifestations to ensure accurate recordkeeping and billing.

    ICD-10-CM Codes

    9 rows

    ICD-10-CM CodeDescription
    A69.0Necrotizing ulcerative stomatitis
    A69.1Other Vincent's infections
    A69.20Lyme disease, unspecified
    A69.21Meningitis due to Lyme disease
    A69.22Other neurologic disorders in Lyme disease
    A69.23Arthritis due to Lyme disease
    A69.29Other conditions associated with Lyme disease
    A69.8Other specified spirochetal infections
    A69.9Spirochetal infection, unspecified

    DRG Codes

    11 rows

    DRG CodeDescription
    011Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with MCC
    012Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with CC
    013Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy without CC/MCC
    152Otitis Media and URI with MCC
    153Otitis Media and URI without MCC
    157Dental and Oral Diseases with MCC
    158Dental and Oral Diseases with CC
    159Dental and Oral Diseases without CC/MCC
    867Other Infectious and Parasitic Diseases Diagnoses with MCC
    868Other Infectious and Parasitic Diseases Diagnoses with CC
    869Other Infectious and Parasitic Diseases Diagnoses without CC/MCC

    Typical Clinical Scenarios

    • An adult presents to the emergency department with a several-day history of high fever, severe headache, myalgias, and a diffuse maculopapular rash after recent exposure to wooded areas and tick bite; blood cultures and serology are pending but the clinician documents suspected acute leptospiral infection with systemic involvement, prompting empiric therapy and inpatient monitoring. A diagnosis from this spirochetal group is assigned for the acute systemic zoonotic infection while confirmatory testing is awaited. Typical codes: A69.0, A69.9
    • A middle-aged patient in outpatient infectious disease follow-up has persistent, intermittent migratory arthralgias, low-grade fever, and fatigue for months after a treated erythema migrans–like illness; evaluation raises concern for chronic manifestations or late sequelae of a spirochetal infection requiring ongoing symptomatic management and specialist assessment. A code from this group is used to capture the chronic/post-infectious spirochetal disease process. Typical codes: A69.21, A69.22
    • A hospitalized patient with poorly controlled diabetes develops a localized suppurative skin and soft tissue infection at a puncture wound that cultures positive for spirochetes, complicated by cellulitis and requiring surgical debridement; the spirochetal infection is recorded as a comorbidity contributing to the acute complication and treatment plan. A code from this group is applied to document the identified spirochetal pathogen as the cause of the complicated soft tissue infection. Typical codes: A69.23, A69.8

    Related Codes

    A65-NONVENEREAL-SYPHILIS

    ICD-10-CM Code For Nonvenereal Syphilis: Group Overview

    A66-YAWS

    ICD-10-CM Code For Yaws: Group Overview

    A67-PINTA-CARATE

    ICD-10-CM Code For Pinta Carate: Group Overview

    A68-RELAPSING-FEVERS

    ICD-10-CM Code For Relapsing Fevers: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.